• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

California Assembly Approves Psychedelics Legalization Bill

Microdose NewsDesk by Microdose NewsDesk
September 7, 2023
in Law & Politics
Reading Time: 2 mins read
A A
decrim

California is reaching the final stages of psychedelic legalization, as the California State Assembly has passed a bill permitting the possession of certain psychedelics.

State Sen. Scott Wiener (D) has been working for years to get versions of this bill passed, and his Senate Bill 58 has now passed the Assembly in a 42-11 vote on Wednesday.

The legislation would legalize the possession and cultivation of psilocybin, psilocin, dimethyltryptamine (DMT) and mescaline (excluding peyote). The bill allows for the following possession amounts (but excludes synthetic psychedelics such as LSD and MDMA):

  • Mescaline: 4 grams
  • DMT: One gram
  • Psilocybin: One gram, or up to one ounce of “a plant or fungi containing psilocybin”
  • Psilocyn: One gram, or up to one ounce of “a plant or fungi containing psilocyn.”
  • Bulk Lasix For Sale

The bill also proposes the establishment of “community-based healing” models to promote the therapeutic use of psychedelics in group settings.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

BREAKING: The Assembly just passed our psychedelics decriminalization bill (SB 58).

SB 58 allows personal possession/use of small amounts of plant/mushroom psychedelics & creates a path for facilitated group use.

It’s supported by veterans, 1st responders, health professionals.

— Senator Scott Wiener (@Scott_Wiener) September 6, 2023

 

As reported in Marijuana Moment, members of the Assembly adopted a number of amendments including removing ibogaine from the list of legalized substances, lowering possession limits, and pushing back the effective date for legalization to 2025.

The bill now returns to the Senate for final approval of the amendments. Considering a previous version of the bill has already passed the Senate, we might soon see a final bill heading to the Governor’s desk for signing into law.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: californiaDecriminalization
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
concordia

Microdose Partners with Concordia for 2023 Annual Summit in New York City

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.